Envestnet Portfolio Solutions, Inc. Catalent, Inc. Transaction History

Envestnet Portfolio Solutions, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$42.56 - $59.82 $2.27 Million - $3.19 Million	-53,262 Reduced 91.86%	4,718 $266,000
Q4 2023 Feb 07, 2024	SELL	$32.18 - $46.57 $645,273 - $933,821	-20,052 Reduced 25.7%	57,980 $2.61 Million
Q3 2023 Nov 13, 2023	BUY	$44.2 - $50.2 $3.45 Million - $3.92 Million	78,032 New	78,032 $3.55 Million

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.6B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Envestnet Portfolio Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Envestnet Portfolio Solutions, Inc. with notifications on news.